Plain-English translation of NCT05301816 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is watching how Nevro's spinal cord stimulation device — a small implant that sends electrical signals to help manage pain — works for people with severe, ongoing leg pain caused by diabetes-related nerve damage. The research is happening across multiple hospitals worldwide and will track how well the treatment actually works in real patients over time.
Many people with diabetic nerve pain don't get enough relief from regular medications alone. This study wants to understand how well this treatment works in everyday practice and whether having diabetes doctors and pain specialists work together can help patients feel better.
If you qualify, you will already have had a trial of the spinal cord stimulation device and experienced good pain relief from it. You'll then have the device permanently implanted and be followed by both your diabetes care team and pain specialists. Throughout the study, you'll attend scheduled visits where doctors will check how you're doing, ask about your pain levels, and monitor your overall health using standard questionnaires and assessments.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
United States